FDA accepts Roche’s sBLA for combination therapy to treat DLBCL

Event Line

2022-08-20

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

2022-08-20

Axsome surges after oral depression drug gets FDA approval

2022-08-19

From FDA:FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

2022-08-18

Bayer gets FDA nod to extend use of popular contraceptive IUD Mirena

2022-08-18

FDA approves Zynteglo gene therapy for beta-thalassemia patients

2022-08-17

Bluebird's $2.8 mln gene therapy for rare blood disorder gets FDA approval

2022-08-17

FDA approves one of the priciest new treatments of all time — bluebirds gene therapy for beta thalassemia

2022-08-17

FDA accepts Roche’s sBLA for combination therapy to treat DLBCL

2022-08-16

FDA grants priority review to Lynparza combo therapy for metastatic prostate cancer

2022-08-16

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

Expand more topics